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The disproportionate body mass and leg length of Achondroplasic individuals may
affect their net oxygen consumption (V˙O2) and metabolic cost (C) when walking at
running compared to those of average stature (controls). The aim of this study was
to measure submaximal V˙O2 and C during a range of set walking speeds (SWS; 0.56 –
1.94 m·s−1, increment 0.28 m·s−1), set running speeds (SRS; 1.67 – 3.33 m·s−1,
increment 0.28 m·s−1) and a self-selected walking speed (SSW). V˙O2 and C was scaled
to total body mass (TBM) and fat free mass (FFM) while gait speed was scaled to
leg length using Froude’s number (Fr). Achondroplasic V˙O2TBM and V˙O2FFM were on
average 29 and 35% greater during SWS (P < 0.05) and 12 and 18% higher during
SRS (P < 0.05) than controls, respectively. Achondroplasic CTBM and CFFM were 29 and
33% greater during SWS (P < 0.05) and 12 and 18% greater during SRS (P < 0.05)
than controls, respectively. There was no difference in SSW V˙O2TBM or V˙O2FFM between
groups (P > 0.05), but CTBM and CFFM at SSW were 23 and 29% higher (P < 0.05)
in the Achondroplasic group compared to controls, respectively. V˙O2TBM and V˙O2FFM
correlated with Fr for both groups (r = 0.984 – 0.999, P < 0.05). Leg length accounted
for the majority of the higher V˙O2TBM and V˙O2FFM in the Achondroplasic group, but
further work is required to explain the higher Achondroplasic CTBM and CFFM at all
speeds compared to controls.
New and Noteworthy: There is a leftward shift of oxygen consumption scaled to total
body mass and fat free mass in Achondroplasic adults when walking and running.
This is nullified when talking into account leg length. However, despite these scalars,
Achondroplasic individuals have a higher walking and metabolic cost compared to
age matched non-Achondroplasic individuals, suggesting biomechanical differences
between the groups.
Keywords: Achondroplasia, oxygen consumption, metabolic cost, walking, running
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INTRODUCTION
Achondroplasia is a condition identified by a disproportionate
shorter limb length relative to torso length compared to
age matched average statured groups, hereafter referred to as
‘controls’ (Hoover-Fong et al., 2007). The absolute shorter lower
limbs of the Achondroplasic population compared to controls is
likely to affect functional tasks, such as walking, which in turn
is likely to affect the oxygen consumption (V˙O2) and metabolic
cost of locomotion (C). For example, increased stride frequency
is observed in proportionally shorter statured groups compared
to taller individuals during walking and running at the same
speeds (Minetti et al., 1994). This in turn leads to a higher
V˙O2 in the shorter groups at set walking speeds (Rowland and
Green, 1988). When gait speed is increased, such as during
incremental walking and running, a positive curvilinear trend of
absolute V˙O2 exists in numerous cohorts (Rowland and Green,
1988; Minetti et al., 1994; Schepens et al., 2004; van den Hecke
et al., 2007). In proportionally shorter statured groups there is a
higher V˙O2 compared to taller groups when walking and running
at set speeds (Rowland and Green, 1988; Minetti et al., 1994;
Schepens et al., 2004; Ludlow and Weyand, 2015). The differences
in V˙O2 between groups of different size can be accounted
somewhat by total body mass (TBM) and fat free mass (FFM)
(Goran et al., 2000; Browning et al., 2006). Scaling horizontal
speed to leg length, as done with Froude’s number (Fr), further
nullifies the observed difference in V˙O2 between shorter and
taller groups during incremental or steady state exercise (Ferretti
et al., 1991; Minetti et al., 1994; Steudel and Beattie, 1995; Steudel-
Numbers et al., 2007; Kramer and Sylvester, 2012). The size, and
therefore mass, of the torso between Achondroplasic individuals
and controls is similar (Owen et al., 1990). But with the leg
length of Achondroplasic individuals being shorter than controls
(Horton et al., 1978), the ratio of torso-to-leg mass is likely to
be greater in the Achondroplasic group, which has been shown
to lead to a higher V˙O2 and C (Griffin et al., 2003; Browning
et al., 2006; Beekley et al., 2007; Peyrot et al., 2009; McCormick,
2014). Furthermore, the shorter Achondroplasic leg would likely
lead to a higher V˙O2 than controls when exercising at the same
speed, as observed in other shorter to taller comparisons (Minetti
et al., 1994). Therefore, separately scaling V˙O2 to either leg
length or body mass during incremental exercise would likely
under- and over-predict an Achondroplasic individual’s V˙O2
when compared to controls. To the authors’ knowledge though,
there are no data pertaining to the measurement of V˙O2 in
Achondroplasic individuals during incremental exercise let alone
the scaling of V˙O2 during incremental exercise.
V˙O2 is useful to describe the cardiovascular response during
exercise, but C describes the oxygen demand over a given distance
(Kramer and Sarton-Miller, 2008). For the same incremental
walking that exhibits a positive trend of V˙O2 described above, a
U-shaped curve of C exists with clear local minima (Ferretti et al.,
1991; Minetti et al., 1994; McCann and Adams, 2002; Kramer and
Sarton-Miller, 2008). This minima suggests that respective slower
and faster walking speeds are less economic, or have a higher
C (i.e., more V˙O2 is required for the given distance). A local
minima is observed at different speeds when stride frequency is
manipulated, suggesting an optimal stride frequency for different
speeds (Minetti et al., 1995). The local minima of C during
walking is observed around self-selected walking (SSW) speed
(Ralston, 1958), but has not been measured alongside set walking
speeds in adults groups of shorter stature (Ferretti et al., 1991;
Minetti et al., 1994, 2002). In groups of shorter stature, their
higher C can be accounted for by their higher stride frequency
(Minetti et al., 1994). The inclusion of a leg length scaler, like
Fr, can nullify the effect of stride frequency while SSW may
explain some of the expected U-shape curve of walking C in
Achondroplasia and controls.
Therefore, the overriding aim of this study was to observe
the relationship between V˙O2 and incremental walking and
running in adults with Achondroplasia. The primary objectives
were to: (1) collect submaximal V˙O2 in Achondroplasic adults
and controls at differing absolute and relative (SSW) intensities
of walking and running; (2) convert V˙O2 into C values and;
(3) attempt to account for any differences in V˙O2 and C by
normalizing to body masses and leg length. It was hypothesized
that Achondroplasia would have a higher V˙O2 and C at all
walking and running speeds, but differences would nullify once
scaled appropriately to mass and leg length.
MATERIALS AND METHODS
Participants
Ten Achondroplasic adults and 17 age matched controls free
from any lower limb injury volunteered to participate in the
study (Table 1). All gave written informed consent, which was
approved by the local committee (Manchester Metropolitan
University) and conformed with the Helsinki declaration. All
participants attended one laboratory session at Manchester
Metropolitan University where anthropometric variables and
V˙O2 were collected during incremental exercise.
Anthropometric Measures
Leg length (m) of all participants was measured as the distance
from the anterior iliac spine to the medial malleolus of the
ankle while standing. Participants’ TBM (kg) was obtained using
electronic scales (SECA 813, CA 91710 Chino, United States)
while barefooted and wearing minimal clothing. FFM was
obtained using Dual Energy x-ray absorptiometry (DEXA).
Following a fasting period of ∼8 h, participants were positioned
TABLE 1 | Anthropometric measures of Achondroplasic adults and controls,
values displayed as mean (SD).
Achondroplasia (N = 10) Control (N = 17)
Age (years) 22 (3) 22 (2)
Stature (m) 1.38 (0.05) ∗ 1.79 (0.08)
Leg Length (m) 0.59 (0.02) ∗ 0.95 (0.05)
TBM (kg) 61.9 (8.7) ∗ 76.5 (10.6)
FFM (kg) 41.3 (5.3) ∗ 55.6 (7.6)
BMI (kg·m−2) 32.4 (3) ∗ 24.1 (4.5)
TBM, total body mass; FFM, fat free mass; BMI, body mass index; ∗P ≤ 0.001.
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on a DEXA scanner (Hologic Discovery, Vertec Scientific Ltd,
United Kingdom) to measure FFM (kg) of the whole body.
Briefly, participants wore a loose-fitting cotton gown and lay
supine in a predefined position that ensured enough space
was between each arm and the torso and between each leg.
The feet were positioned in an internally rotated position
and to maintain participant comfort, and reduce the muscle
activity during the scan, medical tape (TransporeTM Medical
Tape, 3MTM, United States) was wrapped around both feet.
A default whole body scan (EF 8.4 lSv) was selected for all
trials; the scan emitted duel energy (140/100 kVp) fan-beam
x-rays and lasted for ∼7 min. The scanning region was adjusted
depending on stature (Achondroplasia ∼160 cm × 65 cm;
controls∼195 cm× 65 cm) with 1.3 cm line spacing and a 0.2 cm
point resolution and each participant was exposed to ∼8.4 µSv
(Blake et al., 2006). Following all scans manual segmentation of
the body was completed using Physician’s View v6.1 software
in accordance with Hologic’s recommendations. Glickman et al.
(2004) showed that DEXA gives a reliable measurement of TBM
(r = 0.940) and FFM (r = 0.890) against computer tomography,
while the interrater reliability has been shown to be in excess of
0.998 (Hart et al., 2015).
Speed of Locomotion
Selected walking speed trials were completed by participants
conforming to a habitual walking pace around the laboratory
(∼40 m). Each participant passed through two timing gates
(1 m apart), three times. SSW speeds (m·s−1) were calculated
and recorded as an average of the three trials and used in
V˙O2 assessment where individuals’ SSW intersected absolute
speeds described below. V˙O2 collection apparatus (described in
the next section) was worn throughout all exercise trials which
were conducted on a motorized treadmill (Woodway PPS70).
Treadmill speeds were set at 0.56 – 1.94 m·s−1 (increment
0.28 m·s−1) for walking and 1.67 – 3.33 m·s−1 (increment
0.28 m·s−1) for running, as described in Ferretti et al. (1991)
and Minetti et al. (1994, 2002). All trials were completed at 1%
gradient to replicate outdoor conditions (Jones and Doust, 1996)
with each stage being 4 min in duration to attain steady state,
again replicating Ferretti et al. (1991) and Minetti et al. (1994,
2002). Participants rested for ∼5 min following all walking trials
to reduce V˙O2. Where participants could not maintain running
speed for the entirety of the 4 min during any walking and
running intensity, the stage was omitted from analysis and the
testing protocol terminated.
Oxygen Uptake, Metabolic Cost and
Scaling
Expired gasses were collected and analyzed using portable breath-
by-breath indirect calorimetry (Metamax 3B, Cortex, Leipzig
Germany), which was calibrated to the manufacturer’s guidelines
prior to testing. The portable indirect calorimeter (weight = 1 kg)
and a fitted face mask (Hans Rudolph V2, dead space between
125 – 143 ml) were worn by participants during the exercise
bout. Prior to exercise testing, participants lay supine for 5 min
so that resting metabolic rate (L·min−1) could be measured.
Gross V˙O2 for each intensity was recorded with net V˙O2
calculated by subtracting resting metabolic rate from gross V˙O2
as conducted in Minetti et al. (1994, 2002), hereafter net V˙O2
is referred to as ‘V˙O2’. Steady state V˙O2 was determined by
a respiratory exchange ratio < 1.0 and by a visual plateau of
V˙O2 over the final minute of exercise, with V˙O2 recorded as a
rolling average of 6 measurements (every 10 s) for each exercise
intensity. C was presented as the amount of V˙O2 required to
complete 1 km at each gait speed, given as (L·km−1). V˙O2
and C were then normalized to TBM (V˙O2TBM and CTBM,
respectively) and FFM (V˙O2FFM and CFFM, respectively). All
V˙O2 and C values were presented against absolute walking and
running speeds, and against dimensionless Fr, given as: velocity2
(m·s−1)÷ leg length (m)·9.81(m·s−1).
Statistical Analysis
All data were collated onto a personal computer (Macintosh,
MacBook Pro) and analyzed using SPSS (v22.0, IBM). Data were
assumed parametric following Shapiro–Wilk and Levene’s tests.
To avoid a Type I error in the comparisons between groups’ V˙O2
and C measures, a repeated measures ANOVA with a between
effect was used to identify significant differences. However,
only the differences between groups were of interest. Due to
the subtle differences in leg length between Achondroplasic
and control participants, respectively, interpretation of the
interaction between Fr and V˙O2 and C is more difficult. Due to
the linear relationship between V˙O2 and Fr presented elsewhere
(Kramer and Sarton-Miller, 2008), we correlated the mean of
each groups’ Fr and V˙O2 recorded at each walking and running
condition using a Pearson’s correlation. Due to the curvilinear
relationship between C and speed, the relationship between Fr
and C was not inferentially compared. Study power was greater
than 0.80 and alpha was set at ≤ 0.05. All results are reported as
means (SD).
RESULTS
Participant Anthropometrics
There was no difference in age between groups (P = 0.487,
Table 1). Achondroplasia were 23% smaller in stature (P< 0.001),
had a 38% shorter leg (P< 0.001), 19% less TBM (P< 0.001), 26%
less FFM (P < 0.001) but a 25% greater body mass index (BMI,
P < 0.001) than controls (Table 1).
Self-Selected Walking
Achondroplasia were 23% slower than controls at SSW
[Achondroplasia, 1.02 (0.13) m·s−1; control 1.33 (0.14) m·s−1,
P < 0.001].
Incremental Exercise
During V˙O2 assessment, both groups completed all walking
speeds. However, only 50% of the Achondroplasia group
managed to obtain steady state running at 2.50 m·s−1 and only
20% maintained steady state running at 2.78 m·s−1. Therefore,
V˙O2 and C values collected at all walking speeds and at
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running speeds 1.67 – 2.22 m·s−1 were inferentially analyzed
(Figures 1, 2).
Oxygen Consumption
V˙O2TBM were on average 29% greater in Achondroplasia at all
absolute walking speeds apart from SSW where no difference
was observed (Figure 1A). Similarly, Achondroplasia had an
average 35% greater V˙O2FFM at all absolute walking speeds
compared to the control group, with no difference being found
between groups at SSW (Figure 1B). There was no difference
in V˙O2TBM between groups at running speed 1.67 m·s−1, but
Achondroplasia had a 14 and 12% higher V˙O2TBM than controls
at running speeds 1.94 and 2.22 m·s−1 (Figure 1A). A higher
V˙O2FFM was observed in Achondroplasia for all running speeds
(Figure 1B).
Metabolic Cost
On average, Achondroplasia had a 29% higher walking CTBM
and 33% higher walking CFFM when compared to controls
(Figure 1C). Running CTBM were the same between groups at
1.67 and 2.22 m·s−1 (P > 0.05) whereas Achondroplasia had a
higher CTBM than controls at 1.94 m·s−1 (P < 0.05, Figure 1D).
Achondroplasic running CFFM was, on average, 18% higher at all
running speeds compared to controls (P < 0.05, Figure 1D).
Comparison of Froude’s Number (Fr)
Strong positive correlations existed for the Achondroplasic group
between Fr and V˙O2TBM when walking (r = 0.998, P = 0.001)
and running (r = 0.994, P = 0.070), and also for controls
when walking (r = 0.997, P < 0.001) and running (r = 0.985,
P < 0.001, Figure 2A and Table 2). There were also strong
positive correlations for the Achondroplasic group between Fr
and V˙O2FFM when walking (r = 0.999, P < 0.001) and running
(r = 0.993, P = 0.036) and for the control group when walking
(r = 0.997, P < 0.001) and running (r = 0.984, P < 0.001,
Figure 2B and Table 2).
DISCUSSION
The main aim of this study was to attain V˙O2 and C profiles
during incremental walking and running in adult males with
Achondroplasia and compare the results to controls. Further
to this, we aimed to scale V˙O2 and C to body mass and leg
length in both groups. Our hypotheses were partially met in that:
(1) Achondroplasia had a greater V˙O2TBM and V˙O2FFM during
walking and running compared to controls and had a higher
CTBM and CFFM (i.e., a greater V˙O2 for a given distance) at all
walking speeds compared to controls; and, (2) leg length can
FIGURE 1 | Mean SD (error bars) of net oxygen consumption (V˙O2) and metabolic cost (C) for Achondroplasia (◦) and control () when walking (open) and running
(closed) at absolute and SSW speeds (m·s−1); SSW are presented for Achondroplasia (N) and control () respectively. V˙O2 and C are presented relative to total
body bass (A and C, respectively) and relative to fat free mass (B and D, respectively); C is also presented as the energy cost by considering 1 ml of O2 = 20.9 J.
∗P < 0.05 at SSW between groups; †P < 0.05 between groups at paired walking speeds; ‡P < 0.05 between groups at paired running speeds. V˙O2 and C and
speed relationships are fitted with a 2nd order polynomial, with the broken and continuous lines being the trends for the Achondroplasic and control group,
respectively.
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FIGURE 2 | Mean net oxygen consumption (V˙O2) and metabolic cost (C) for Achondroplasia (◦) and control () when walking (open) and running (closed) at mean
Froude’s numbers (Fr); SSW are presented for Achondroplasia (N) and control () respectively. V˙O2 and C are presented relative to total body bass (A and C,
respectively) and relative to fat free mass (B and D, respectively); C is also presented as the energy cost by considering 1 ml of O2 = 20.9 J. V˙O2 and Fr relationships
are fitted with a linear trend line, while C and Fr relationships are fitted with a 2nd order polynomial with the broken and continuous line being the trends for the
Achondroplasic and control group, respectively. SD is omitted for clarity.
explain some of the difference in V˙O2TBM and V˙O2FFM between
groups but not for CTBM and CFFM.
Oxygen Consumption
Achondroplasic V˙O2TBM and V˙O2FFM was higher at every
walking and running speed compared to controls other than
SSW which were the same between groups. This is similar to
previous reports, where shorter statured groups have higher
V˙O2TBM than taller counterparts during locomotion (Rowland
and Green, 1988; Minetti et al., 1994; Schepens et al., 2004;
Ludlow and Weyand, 2015). The higher Achondroplasic V˙O2TBM
and V˙O2FFM at set speeds is most likely due to a higher stride
frequency of the Achondroplasic group, which is a result of
their shorter legs, as Minetti et al. (1994) partially confirmed
that higher stride frequency was the cause of higher V˙O2TBM
in their African Pygmy group. While stride frequency was not
measured in the present study, the data presented by Minetti
et al. (1994) would infer some similarities between groups. The
Pygmies included in Minetti et al. (1994) were 16 cm taller than
the presented Achondroplasic group while the control groups
were 1 cm different. With Pygmies being smaller and having a
higher stride frequency compared to controls, it is likely that the
even smaller Achondroplasic group had a similar, if not higher,
stride frequency to the Pygmies.
While this study does not directly measure factors that explain
the higher V˙O2 of the Achondroplasic group for a given speed
of locomotion, there are a number of mechanisms that could
explain these data. Firstly, the probable higher stride frequency
of the Achondroplasic group would lead to a greater amount of
internal mechanical work being done compared to controls, as
observed in other shorter statured groups (Ferretti et al., 1991;
Minetti et al., 1994; DeJaeger et al., 2001; Minetti et al., 2002;
Schepens et al., 2004; Weyand et al., 2010). A higher internal work
not only requires energy to complete the work but would also
elicit a greater rate of muscular contraction. Assuming the fiber
type distribution is the same between groups, the rate of muscular
contraction is likely to alter the force-velocity relationship of
the Achondroplasic muscle (Fletcher and MacIntosh, 2017). In
this scenario, the Achondroplasic muscle would be producing
less force due to the quicker movement of the limbs. Muscle
activation could therefore be higher in the Achondroplasic group
to recruit the fibers required to maintain locomotion forces,
therefore leading to a higher oxygen demand (Mian et al.,
2006). However, internal work, force production (relative to gait
requirements) and muscle activation have not been measured in
Achondroplasic individuals during gait and therefore more work
is required in this area to help confirm these theories. To try an
account for the assumed higher Achondroplasic stride frequency,
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TABLE 2 | R2 values for Froude and scaled V˙O2 relationships in Achondroplasic
individuals and controls during walking and running.
Achondroplasia Control
Walking Running Walking Running
V˙O2 (ml·kg−1·min−1) 0.997 0.988 0.994 0.985
V˙O2 (ml·kgFFM−1·min−1) 0.997 0.987 0.994 0.984
All correlations significant to P < 0.001.
and therefore eliminate some of the above, we normalized
horizontal speed using leg length in the form of Fr.
Comparisons of Froude’s Number (Fr)
In the current study, Fr could explain the variability of the groups’
V˙O2TBM and V˙O2FFM by as little as 98.7% (Figures 2A,B and
Table 2). This matches much of the literature where Fr has been
used to compare the relationship between leg length and V˙O2
during locomotion. Ferretti et al. (1991) and Minetti et al. (1994)
showed African Pygmy’s V˙O2TBM and Fr trends are similar to
controls, with Minetti et al. (2002) also observing similar findings
in patients with GHD. The similarity of the V˙O2 and Fr trends
between groups suggests that the difference in groups’ V˙O2TBM
and V˙O2FFM can be accounted for by the shorter Achondroplasic
leg. The similarity in the slopes are not surprising given that V˙O2
correlates well with TBM and FFM (Goran et al., 2000; Weibel
and Hoppeler, 2005). It is important to note here though, that
although the relationships appear similar between the groups
and between mass scalers (Table 2), each mass scaler should
not be used to estimate another. For example, in both groups
a Fr of ∼0.30 elicits a V˙O2TBM ∼15 ml·kg−1·min−1, whereas
the same Fr elicits a V˙O2FFM ∼20 ml·kg−1·min−1. While the
inclusion of Fr accounted for the difference in V˙O2 by providing
similar slopes for both V˙O2TBM and V˙O2FFM between groups
respectively, Fr did not explain the difference in C between
groups.
Metabolic Cost
While V˙O2 is a useful parameter, it only describes the rate at
which O2 is used, not the usage per unit distance. In contrast,
C provides O2 usage per unit distance and can be converted into
energy cost, assuming an energy equivalent of 20.9 J per 1 ml O2
(Figures 1B,D) and describes the energetic cost per unit mass and
distance. Despite accounting for mass and distance traveled, the
Achondroplasic group exhibited a higher CTBM and CFFM during
walking and running than controls. In addition, CTBM and CFFM
at SSW occurred near the local minima of the trend lines for both
groups but remained different between groups. The factors that
may account for the difference in C between groups are again
not investigated directly in this paper, but the available literature
does allow insight into potential reasons to why these differences
exists.
The torso size of Achondroplasic people and controls is the
same when measured as sitting height (Owen et al., 1990). With
the Achondroplasic legs being shorter than controls, one would
assume that Achondroplasic people have a larger torso to TBM
ratio than controls. Where additional mass is added to the torso
of individuals exercising on a treadmill, a higher C is observed
compared to individuals without additional mass (Griffin et al.,
2003; Browning et al., 2006, 2007; Beekley et al., 2007; Peyrot
et al., 2009; McCormick, 2014); the converse is observed when
body weight is reduced through assisted treadmill running
(Grabowski and Kram, 2008). While the present Achondroplasic
participants were lighter than the control group, the additional
torso mass of the Achondroplasic group would have implications
for the contractile properties of their smaller lower leg muscles
during stance. Firstly, relative to lower leg muscle mass, a greater
vertical ground reaction force (vGRF) would be observed in
the Achondroplasic group. The smaller muscle fibers of the
Achondroplasic lower limbs (Sims et al., 2017) would therefore
do more external work during the braking phase of stance to
compensate for the relatively larger vGRF, eliciting a higher C
(Pontzer, 2005; Grabowski and Kram, 2008). Furthermore, we
recently showed that Achondroplasic adults have a greater co-
activation of their antagonists during knee extension (Sims et al.,
2017). Although this was during maximal voluntary contraction,
it is possible that during the propulsion phase of gait, there is
greater co-activation of the hamstrings. Previously, a higher co-
activation during gait contributes to negative work which is partly
associated with a higher C (Mian et al., 2006). These theories
though, require further work to help explain the difference in C
between Achondroplasic individuals and controls.
Implications and Future Work
In the present study, the difference in C between groups
could possibly be explained by biomechanical differences that
have previously been shown to alter or determine C, such as
mass distribution and inertial properties (Griffin et al., 2003;
Browning et al., 2006, 2007; Beekley et al., 2007; Peyrot et al.,
2009; McCormick, 2014), tendon compliance (Arampatzis et al.,
2006; Fletcher et al., 2010; Albracht and Arampatzis, 2013)
and internal and external work (Ferretti et al., 1991; Minetti
et al., 1994, 2002); further work is required in Achondroplasic
populations to determine whether these factors play a role in
explaining the present results. The current data does show that
leg length can explain some of the variance in V˙O2TBM and
V˙O2FFM between the presented groups, i.e., longer legs equate
to a lower walking and running V˙O2 and in turn suggests
a lower walking and running C. Therefore, the lengthening
of the Achondroplasic leg would possibly lower C and make
some ambulatory based activities of daily living less energetically
demanding. Although a viable option, leg lengthening surgery
for an Achondroplasic individual is, however, a highly invasive
long-term surgical procedure involving prolonged recovery and
imposed sedentary behavior (Park et al., 2015). Were other
interventions explored to help improve Achondroplasic C during
activities of daily living, it is probably that such tasks would be
completed more often. It is probable thereafter that their physical
activity levels would be improved, as has been observed in an
obese population (Weinsier et al., 2000), which is then likely
to lower the risk of health complications (Wilmot et al., 2012).
Further work should therefore be directed toward identifying
exercise interventions that are associated with lowering C
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in Achondroplasic populations, such as those identified in
control populations described above, and then be appropriately
addressed in Achondroplasic populations.
CONCLUSION
This study aimed to observe the relationship between V˙O2 and
incremental walking and running speeds in adult males with
Achondroplasic. To the author’s knowledge, this is the first study
to scale and compare V˙O2 and C during walking and running
between Achondroplasic males and controls. The main findings
are that (1) Achondroplasic V˙O2TBM and V˙O2FFM are higher
at all walking and running speeds compared to controls; (2)
V˙O2TBM and V˙O2FFM is not different between groups at SSW;
(3) CTBM and CFFM are higher in Achondroplasia than controls
at all walking and running speeds, and 4) the inclusion of leg
length as a scaler helps explain V˙O2 differences but not C
differences between groups. The higher Achondroplasic V˙O2TBM
and V˙O2FFM is most likely due to a higher stride frequency, while
their higher CTBM and CFFM is likely due to anthropometrical
differences compared to controls.
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